Clinical Trial Update: Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/3 clinical trial evaluating oral phytate (inositol hexakisphosphate) for preventing progression of cardiovascular calcifications in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Heart Valve Disease

Drugs mentioned

• Phytate (InsP6) (inositol hexakisphosphate)

Snippet

Sponsor: Hospital Universitari Son Dureta | Conditions: Heart Valve Disease, Aortic Stenosis | Phase 2, Phase 3 | Status: UNKNOWN